PCM
AGN

Pentwater Capital Management’s Allergan plc AGN Stock Holding History

Pentwater Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,694,042
Closed -$300M – 186
2020
Q1 		$300M Buy
1,694,042
+1,639,712
+3,018% +$309M 4.95% 4
2019
Q4 		$10.4M Buy
54,330
+49,100
+939% +$8.86M 0.17% 61
2019
Q3 		$880K Sell
5,230
-3,570,770
-100% -$582M 0.01% 113
2019
Q2 		$599M Buy
3,576,000
+3,554,000
+16,155% +$492M 6.43% 3
2019
Q1 		$3.22M Hold
22,000
– – 0.04% 77
2018
Q4 		$2.94M Sell
22,000
-6,000
-21% -$984K 0.03% 76
2018
Q3 		$5.33M Sell
28,000
-5,500
-16% -$1.01M 0.05% 69
2018
Q2 		$5.58M Hold
33,500
– – 0.04% 69
2018
Q1 		$5.64M Sell
33,500
-62,500
-65% -$10.5M 0.04% 69
2017
Q4 		$15.7M Buy
96,000
+42,000
+78% +$7.54M 0.1% 57
2017
Q3 		$11.1M Buy
54,000
+36,000
+200% +$8.37M 0.1% 61
2017
Q2 		$4.38M Sell
18,000
-1,000
-5% -$235K 0.04% 79
2017
Q1 		$4.54M Sell
19,000
-348,547
-95% -$81.2M 0.06% 64
2016
Q4 		$77.2M Sell
367,547
-1,045,453
-74% -$217M 0.99% 22
2016
Q3 		$325M Sell
1,413,000
-347,868
-20% -$85M 3.02% 6
2016
Q2 		$407M Sell
1,760,868
-3,050,500
-63% -$703M 5.44% 5
2016
Q1 		$1.29B Buy
4,811,368
+495,000
+11% +$142M 9.47% 2
2015
Q4 		$1.35B Buy
4,316,368
+4,288,321
+15,290% +$1.28B 9.24% 3
2015
Q3 		$7.62M Buy
28,047
+17,400
+163% +$5.34M 0.07% 82
2015
Q2 		$3.23M Sell
10,647
-1,800
-14% -$537K 0.02% 134
2015
Q1 		$3.7M Buy
+12,447
New +$3.55M 0.03% 120
2014
Q4 		– Sell
-62,500
Closed -$15.6M – 179
2014
Q3 		$15.1M Buy
+62,500
New +$14M 0.15% 84

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Pentwater Capital Management's AGN Position: Q2 2020 in Review

Pentwater Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,694,042 shares — an estimated $300M sold.

Pentwater Capital Management first reported a position in AGN in Q3 2014 and held it in 22 quarters. The position peaked at $1.35B in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Pentwater Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Pentwater Capital Management sold 1,694,042 Allergan plc shares in Q2 2020, an estimated $300M.
  • Pentwater Capital Management first reported a position in Allergan plc in Q3 2014 and held it in 22 quarters.
  • Pentwater Capital Management's Allergan plc position peaked at $1.35B in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Pentwater Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.